TNFSF10 and neoplasm: Interestingly, it has been demonstrated that concomitant administration of chemotherapy and recombinant TRAIL may restore sensitivity to TRAIL-induced apoptosis in primary TRAIL-resistant tumor cells (Micheau et al., 2013).